Young-Ah Lucy Lee

Young-Ah Lucy Lee

Auto-generated profile, based on publicly available information

Young-Ah Lucy Lee

Department of Chemical Engineering and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2015 in Nature Materials
Verified
Journal Article
Open access
PDF file
SZShiyi Zhang
Shiyi Zhang
ABAndrew M. Bellinger
Andrew M. Bellinger
DGDean L. Glettig
Dean L. Glettig
RBRoss Barman
Ross Barman
YLYoung-Ah Lucy Lee
Young-Ah Lucy Lee
GTGiovanni Traverso
Giovanni Traverso
Devices resident in the stomach—used for a variety of clinical applications including nutritional modulation for bariatrics, ingestible electronics for diagnosis and monitoring, and gastric-retentive dosage forms for prolonged drug delivery—typically incorporate elastic polymers to compress the devices during delivery through the oesophagus and other narrow orifices in the digestive system. However, in the event of accidental device fracture or migration, the non-degradable nature of these materials risks intestinal obstruction. Here, we show that an elastic, pH-responsive supramolecular gel remains stable and elastic in the acidic environment of the stomach but can be dissolved in the neutral-pH environment of the small and large intestines. In a large animal model, prototype devices with these materials as the key component demonstrated prolonged gastric retention and safe passage. These enteric elastomers should increase the safety profile for a wide range of gastric-retentive devices.

16 November 2016 in Science Translational Medicine
Verified
Journal Article
Closed access
ABAndrew M. Bellinger
Andrew M. Bellinger
MJMousa Jafari
Mousa Jafari
TGTyler M. Grant
Tyler M. Grant
SZShiyi Zhang
Shiyi Zhang
HSHannah C. Slater
Hannah C. Slater
GTGiovanni Traverso
Giovanni Traverso
A newly developed platform capable of oral, ultra–long-acting drug delivery could be applied against the malaria vector in elimination programs.

9 January 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
AKAmeya R. Kirtane
Ameya R. Kirtane
OAOmar Abouzid
Omar Abouzid
DMDaniel Minahan
Daniel Minahan
TBTaylor Bensel
Taylor Bensel
AHAlison L. Hill
Alison L. Hill
GTGiovanni Traverso
Giovanni Traverso
The efficacy of antiretroviral therapy is significantly compromised by medication non-adherence. Long-acting enteral systems that can ease the burden of daily adherence have not yet been developed. Here we describe an oral dosage form composed of distinct drug–polymer matrices which achieved week-long systemic drug levels of the antiretrovirals dolutegravir, rilpivirine and cabotegravir in a pig. Simulations of viral dynamics and patient adherence patterns indicate that such systems would significantly reduce therapeutic failures and epidemiological modelling suggests that using such an intervention prophylactically could avert hundreds of thousands of new HIV cases. In sum, weekly administration of long-acting antiretrovirals via a novel oral dosage form is a promising intervention to help control the HIV epidemic worldwide.

25 July 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
Jinyao LiuJinyao Liu
Jinyao Liu
YPYan Pang
Yan Pang
SZShiyi Zhang
Shiyi Zhang
CCCody Cleveland
Cody Cleveland
XYXiaolei Yin
Xiaolei Yin
GTGiovanni Traverso
Giovanni Traverso
Systems capable of residing for prolonged periods of time in the gastric cavity have transformed our ability to diagnose and treat patients. Gastric resident systems for drug delivery, ideally need to be: ingestible, be able to change shape or swell to ensure prolonged gastric residence, have the mechanical integrity to withstand the forces associated with gastrointestinal motility, be triggerable to address any side effects, and be drug loadable and release drug over a prolonged period of time. Materials that have been primarily utilized for these applications have been largely restricted to thermoplastics and thermosets. Here we describe a novel set of materials, triggerable tough hydrogels, meeting all these requirement, supported by evaluation in a large animal model and ultimately demonstrate the potential of triggerable tough hydrogels to serve as prolonged gastric resident drug depots. Triggerable tough hydrogels may be applied in myriad of applications, including bariatric interventions, drug delivery, and tissue engineering.

27 June 2018 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
WLWon‐Kyu Lee
Won‐Kyu Lee
WJWoo‐Bin Jung
Woo‐Bin Jung
DRDongjoon Rhee
Dongjoon Rhee
JHJingtian Hu
Jingtian Hu
YLYoung‐Ah Lucy Lee
Young‐Ah Lucy Lee
TOTeri W. Odom
Teri W. Odom

6 April 2016 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
YLYoung‐Ah Lucy Lee
Young‐Ah Lucy Lee
SZShiyi Zhang
Shiyi Zhang
JLJiaqi Lin
Jiaqi Lin
RLRobert Langer
Robert Langer
GTGiovanni Traverso
Giovanni Traverso